1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Wesana Health Holdings Inc.
  6. News
  7. Summary
    WESA   CA95081C1059

WESANA HEALTH HOLDINGS INC.

(WESA)
  Report
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  03:36 2022-08-11 pm EDT
0.1700 CAD   -5.56%
06/08WESANA HEALTH CEO DANIEL CARCILLO TO KEYNOTE CHARLES RIVER SYMPOSIUM : Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies
AQ
05/31Wesana Announces First Quarter 2022 Financial Results
AQ
05/31Wesana Health Holdings Inc. Announces Resignation of Chad Bronstein as Executive Chairman
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Wesana Health Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2021

05/02/2022 EDT

Wesana Health Holdings Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was USD 0.267205 million compared to USD 0.030201 million a year ago. Net loss was USD 34.34 million compared to USD 0.087181 million a year ago. Basic loss per share from continuing operations was USD 1.48 compared to USD 0.02 a year ago.


© S&P Capital IQ 2022
All news about WESANA HEALTH HOLDINGS INC.
06/08WESANA HEALTH CEO DANIEL CARCILLO TO : Re-Imagining Substance Abuse, Addiction, and Mental..
AQ
05/31Wesana Announces First Quarter 2022 Financial Results
AQ
05/31Wesana Health Holdings Inc. Announces Resignation of Chad Bronstein as Executive Chairm..
CI
05/30Wesana Health Holdings Inc. Reports Earnings Results for the First Quarter Ended March ..
CI
05/10Wesana Health Outlines Accelerated Drug Development Pathway
AQ
05/10Wesana Health Holdings Outlines Accelerated Drug Development Pathway
CI
05/05Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its..
AQ
05/05Wesana Health Holdings Announces Review of Strategic Alternatives of its Clinics and Ot..
CI
05/02Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highligh..
AQ
05/02Wesana Health Holdings Inc. Reports Earnings Results for the Full Year Ended December 3..
CI
More news
Financials (USD)
Sales 2022 1,56 M - -
Net income 2022 -21,8 M - -
Net Debt 2022 - - -
P/E ratio 2022 -0,27x
Yield 2022 -
Capitalization 2,72 M 2,72 M -
Capi. / Sales 2022 1,75x
Capi. / Sales 2023 0,99x
Nbr of Employees -
Free-Float 99,1%
Chart WESANA HEALTH HOLDINGS INC.
Duration : Period :
Wesana Health Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 0,13 $
Average target price 3,09 $
Spread / Average Target 2 219%
EPS Revisions
Managers and Directors
Daniel Carcillo Chief Executive Officer & Director
Zed Wang Chief Financial Officer & Secretary
Chad Bronstein Executive Chairman
Mark Wingertzahn Chief Scientific Officer
Mitchell Kahn Director
Sector and Competitors
1st jan.Capi. (M$)
WESANA HEALTH HOLDINGS INC.-88.11%3
MODERNA, INC.-32.35%67 212
LONZA GROUP AG-23.32%46 073
IQVIA HOLDINGS INC.-14.23%45 135
SEAGEN INC.12.57%32 099
ALNYLAM PHARMACEUTICALS, INC.35.27%27 533